MedicinePsychology

Maternal Immune Activation as a Risk Factor for Schizophrenia: Evidence From Preclinical and Clinical Studies

Camila N. C. Lima, Tejaswini Doifode, Allan Colodel, P. Sayana, V. Giridharan, D. Macêdo, Omar Pinjari, T. Barichello

2020Progress in Inflammation Research

DOI: 10.1007/978-3-030-39335-9_9

tlooto Summary

Outcomes from the preclinical MIA models as well as results from recent clinical studies corroborating the effects of MIA on the neurodevelopment of the offspring are described.

Abstract

Abstract is not available.

Citation format

LIMA, Camila N. C., et al. Maternal immune activation as a risk factor for schizophrenia: Evidence from preclinical and clinical studies. Progress in Inflammation Research, 2020.